Since the identification of fat soluble A a century ago (1), retinoids (vitamin A and its natural and synthetic analogs) have been the most extensively studied of the fat soluble vitamins. This research has identified essential roles for retinoids in many different aspects of mammalian physiology including embryonic development, adult growth and development, maintenance of immunity, maintenance of epithelial barriers and vision (1) (2) (3) (4) (5) . This review will focus on retinoid biochemistry in mammals, primarily on retinol and retinyl ester metabolism. However, we also will consider other retinol metabolites including retro-and anhydro-retinoids and retinoid--glucuronides.
lacking RetSat exhibit increased adiposity, which is associated with an up-regulation of PPAR (25) . Future studies may identify other novel metabolites of retinol, possibly generated by RetSat, which may explain these phenotypes.
Over the last four decades many retinoid metabolites have been identified (6, 7, 20, 21) . Some of these are proposed but not proven to have important physiological roles whereas others are simply catabolic products destined for elimination from the body. It is possible that some of these metabolites may yet prove to be very important physiologically, but we have chosen to consider in our review only those associated with a relatively substantial literature. The reader should turn to earlier review articles (6, 7, 20) , for more details regarding these other retinoid metabolites.
Retinol esterification and retinyl ester hydrolysis.
Although the liver and intestine are the major tissue sites of retinol esterification in the body, many tissues are able to esterify retinol and accumulate some retinyl ester stores, including the eye, lung, adipose tissue, testes, skin, spleen and others (6, 7) . It is now understood that the enzyme responsible for the preponderance of retinyl ester formation in the body is lecithin:retinol acyltransferase (LRAT). This understanding was obtained from study of mutant mice where the gene encoding LRAT had been totally ablated (26) (27) (28) . Lrat-deficient mice possess significant retinyl ester stores only in adipose tissue but not in liver, eyes, lungs, testes, skin or spleen (26) (27) (28) (29) . LRAT catalyzes a transesterification, transferring long chain fatty acyl moieties (primarily palmitic, stearic, oleic and linoleic acids) present at the sn-1 position of membrane bilayer phosphatidylcholine to retinol, forming retinyl esters (6, 7, (30) (31) (32) (33) (34) . LRAT is one by guest, on October 22, 2017 www.jlr.org Downloaded from of 6 distinct proteins/genes which compose the vertebrate members of the NIpC/P60 protein family (35) . Members of this protein family share a common property of having conserved cysteine, histidine and polar amino acid residues that are required for catalytic activity (35) . The other vertebrate member of this family that is relatively well studied is adipose-specific phospholipase A2 (AdPLA) (36, 37) . AdPLA was described by Sul and colleagues as a phospholipase that is associated with the development of obesity induced by high fat feeding (37) . The other vertebrate members of this protein family are less well studied and are reported to possess either phospholipase and/or phosphatidylcholine-dependent acyltransferase activities (38) (39) (40) (41) (42) . Some show a sn-1 preference and others a preference for the sn-2 acyl moiety (38) (39) (40) (41) (42) . It should be noted that LRAT is completely distinct from, and shares no relationship with, lecithin:cholesterol acyltransferase (LCAT).
The older literature suggests that another enzymatic activity may be physiologically important for catalyzing retinyl ester formation, acyl-CoA:retinol acyltransferase (ARAT). ARAT is proposed to esterify retinol using fatty acyl groups present in the acyl-CoA pool (33) . ARAT also is reported to differ from LRAT with regards to its ability to acquire retinol within the cell. LRAT is capable of esterifying retinol when it is bound to one of the cellular retinol-binding proteins (CRBPI, CRBPII, or CRBPIII), whereas ARAT is not (34) . Several published studies have established that one of the two enzymes responsible for the final step in triglyceride synthesis, diacylglycerol acyltransferase 1 (DGAT1), possesses ARAT activity in vitro (28, (43) (44) (45) (46) . DGAT1, when expressed in vitro, will catalyze retinyl ester formation using non-protein bound retinol as a substrate but is unable to catalyze retinyl ester formation when the by guest, on October 22, 2017 www.jlr.org Downloaded from retinol is supplied bound to CRBPI or CRBPII (28) . When Lrat-deficient mice were challenged with an oral physiological dose (6 µg) of retinol provided in oil, some retinyl esters were still present in nascent chylomicrons (28) . When this same oral challenge was given to mice totally lacking expression of both Lrat and Dgat1, no retinyl esters could be detected in newly synthesized chylomicrons (47) . This observation was taken to indicate that DGAT1 acts in vivo as an intestinal ARAT (47) . Interestingly, when an oral pharmacological dose (1.0 mg) of retinol in oil was given to the mice lacking both Lrat and Dgat1, some retinyl esters were observed in the postprandial circulation (47) .
This observation suggests that a third enzyme is able to esterify retinol in the intestine when very high levels of retinol have been consumed. Studying Dgat1-deficient mice, Farese and colleagues independently established that DGAT1 can influence retinoid homeostasis in the skin of mice (44) . Thus, in at least two mouse tissues, intestine and skin, DGAT1 acts physiologically in catalyzing retinyl ester formation. As noted above, Lrat-deficient mice possess significant retinyl ester stores in adipose tissue (28, 29) . This is also true for mice totally lacking both Lrat and Dgat1 (47) . This observation implies that another as yet unidentified enzyme acts in adipose tissue to catalyze retinyl ester formation.
LRAT in the liver is thought to be structurally identical to intestinal LRAT, which synthesizes retinyl esters from dietary retinol for incorporation into nascent chylomicrons. Interestingly though, hepatic but not intestinal LRAT expression is regulated by retinoid nutritional status (48) . The regulation of expression of the Lrat gene in the liver involves the presence of a retinoic acid response element present in the Lrat gene, and probably the actions of retinoic acid receptors (RARs) and/or RXRs by guest, on October 22, 2017 www.jlr.org Downloaded from (48, 49) . This retinoic acid-responsive regulation is proposed to give rise to a positive feedback loop when cellular retinoic acid levels are high, turning on Lrat expression and increasing the synthesis of retinyl esters and preventing the synthesis of additional retinoic acid. Supporting this proposal is the observation that hepatic expression levels of the retinoic acid catabolic enzyme, Cyp26A, (which is also a retinoic acid responsive gene), are markedly upregulated in Lrat-deficient mice (27, 28) . In addition to a role for retinoic acid in regulating Lrat gene expression, studies carried out in the PC-3 prostate cancer cell line indicate that GATA transcription factors also act importantly in regulating Lrat transcription (49) .
Since retinyl esters represent a retinoid storage form, they must be hydrolyzed to retinol before conversion to retinoic acid. Unlike LRAT, which is accepted to be the major enzyme responsible for retinyl ester formation, there are many retinyl ester hydrolases (REHs) that are proposed to be responsible physiologically for the generation of free retinol from retinyl ester stores (50) (51) (52) . One is a bile salt-dependent retinyl ester hydrolase. Most or all of this enzymatic activity in the liver probably arises from the actions of bile salt-activated carboxylester lipase (CEL) (53). However, since mice lacking CEL display no alterations in retinoid storage, metabolism or actions, so this enzyme cannot be the sole physiologically relevant REH (53). Another group of enzymes, collectively known as bile salt-independent REHs have been described.
Based on their pH optima, there are two groups of bile-salt independent REHs, neutral Harrison (54) in this Thematic Series for further consideration of this point.
Retinoid-binding proteins.
In order to solubilize, protect and detoxify retinoids in the aqueous intracellular and extracellular environment, retinol, retinal and retinoic acid are bound to specific retinoidbinding proteins (6, 7, 55) . These binding proteins can be classified using several different criteria. Some of these proteins, specifically retinol-binding protein (RBP4), interphotoreceptor matrix retinoid-binding protein (IRBP), epididymal retinoid-binding protein (ERBP), and b-trace are found in extracellular fluids, whereas the remaining are found only intracellularly (6, 7, (55) (56) (57) (58) (59) (60) (61) (62) (63) (64) (65) (63) and cellular retinol-binding protein, type IV (CRBPIV) (64)); and one that preferentially binds retinal (cellular retinal-binding protein (CRALBP) (55, 60, 62, 65) ). These proteins can also be grouped by the protein families to which they belong. RBP4, ERBP and b-trace are all members of the lipocalin protein family (55) (56) (57) (58) (59) . CRBPI, -II, -III, and IV as well as CRABPI and CRABPII are members of the fatty acid-binding protein family of proteins (55, 57, 60, 61, 63, 64) . CRALBP is a member of the CRAL-TRIO protein family that also contains the vitamin Ebinding protein, -tocopherol-transport protein (TTP) (65) . For more details on TTP and vitamin E, the reader is referred to the review from Traber in this Thematic Series (66) .
Each of the known retinoid-binding proteins has been proposed to have a role in facilitating retinoid transport and/or metabolism. However, most if not all of these proteins do not have essential roles in facilitating these processes as the genes for nearly all of these retinoid-binding proteins have been ablated in mouse models and none of the gene disruptions is lethal or associated with a severe phenotypes (67) (68) (69) (70) (71) (72) (73) .
It seems likely that these proteins are needed to facilitate optimal retinoid retention, CRBPII is present at high concentrations in the enterocytes and binds both retinal and retinol (55, 75) . Retinal, formed upon proretinoid carotenoid cleavage by BCMO1, binds to CRBPII and this is proposed to be the preferred substrate for reduction to retinol by an intestinal retinal reductase. Retinol bound to CRBPII is then re-esterified to long chain fatty acids predominantly through the action of LRAT, which utilizes retinol bound to CRBPII as a substrate for esterification (55, 60, 75) . The resulting retinyl esters are then packaged along with the rest of the dietary lipids into nascent chylomicrons and secreted into the lymphatic system for uptake into the general circulation (6, 7). The molecules and molecular events responsible for the intestinal absorption of retinoids and carotenoids are considered in more detail elsewhere in this Thematic Series (54) .
Transport in the postprandial and fasting circulations.
A number of different retinoids are found in the circulation and these differ in the fasting and postprandial states. These potential retinoid delivery pathways are summarized in Figure 3 . They include: retinyl esters in chylomicrons, chylomicron remnants, very low-density lipoprotein (VLDL), low-density lipoprotein (LDL) and high density lipoprotein (HDL); retinol bound to retinol-binding protein (RBP4); retinoic acid bound to albumin; and the water-soluble -glucuronides of retinol and retinoic acid. In the postprandial circulation following consumption of a retinoid-rich meal, retinyl ester concentrations in the 5-10 µM range can be reached (76) , although this will depend directly on the quantity of retinoid consumed in the meal. The liver secretes some retinyl ester bound to nascent VLDL, and, upon metabolism of the VLDL, some of this retinyl ester can be found in LDL or transferred to HDL in species which express cholesteryl ester transfer protein.
Concentrations of retinyl esters in the fasting circulation can vary but are generally in the range of 100-200 nM (77) . In the fasting circulation, retinol bound to RBP4 is the predominant retinoid species with normal concentrations ranging from 2-4 µM in humans and around 1 µM in mice (28, 56, 78) .
In the circulation, the retinol-RBP4 complex binds another plasma protein, transthyretin (TTR), and this stabilizes the complex, reducing renal filtration of the retinoid (56, 79).
Retinoic acid is present in both the fasting and postprandial circulations where it is found bound to albumin. Nau and colleagues have reported that immediately following consumption of a retinoid-rich meal consisting of 100 g of turkey liver, human blood levels of retinoic acid can reach 80-90 nM (76). However, this level is quickly restored by the body to fasting levels that range from 1-3 nM (76, 80). The half-life of plasma all-trans-retinoic acid in a fasted chow fed rat is very short, with the plasma pool completely turning over every 2 minutes (80). The studies of Nau and colleagues (76) suggest that the intestine contributes significantly to the retinoic acid that is present in the postprandial circulation. The tissues responsible for contributing retinoic acid to the fasting circulation remain to be established. At the present time, it is unclear whether only one or a few tissues contribute to the circulating retinoic acid pool or whether retinoic acid is simply "leaking" into the fasting circulation from most or all tissues.
Plasma/serum concentrations of retinyl-and retinoyl--glucuronides were reported by Olson and colleagues to be in the range of 5-15 nM (81, 82) . Although it has been proposed that retinyl-and retinoyl--glucuronides, which are known to be readily hydrolyzed by a number of -glucuronidases (6, 7), may serve as sources of retinoids for tissues, it is generally believed that these fully water soluble metabolites are filtered in the kidney and eliminated quickly from the body.
In addition to preformed retinoid delivery through the circulation, proretinoid carotenoids like -carotene are absorbed intact by the intestine and these too can be found in the blood bound to chylomicrons and their remnants, VLDL, LDL, and HDL (83, 84). Since many tissues, including liver, lungs, and testes, express BCMO1, intact carotenoid delivered to these tissues can be converted in situ to retinoids that may be needed for supporting retinoid-dependent functions. Fasting blood levels of the canonical proretinoid carotenoid -carotene in humans, a species which absorbs carotenoids well, can be as great as 5-8 µM (84) . Although the mouse, owing to its ability to be genetically manipulated, is presently being used to study -carotene uptake from the diet, as well as -carotene metabolism and physiologic actions, it should be noted that rodents are very poor absorbers of -carotene. Consequently, studies involving the feeding of -carotene to mice must employ very high concentrations of -carotene in the diet, concentrations which are many times greater than those which would be found in any human diet.
As can be surmised from the text above, the delivery of retinoids to tissues is complex, involving many different retinoid forms and carriers. Quantitatively the two most important pathways are those involving retinol bound to RBP4 and the postprandial delivery pathway. However, the importance of retinoic acid delivery to tissues from the blood should not be discounted, since the accumulation of retinoic acid from the blood is tissue-dependent (80). In this regard, the delivery of retinoid to proposed that LRAT is a critical component of this process (101) . In vitro experiments have established that STRA6 facilitates efficient retinol exchange between intercellular CRBPI and extracellular RBP4 (100). Recently, mice lacking STRA6 were generated and studied (102) . These mice are viable and generally normal. The primary phenotype of the Stra6-deficient mice is a visual one, similar to the mice lacking Rbp4 (71, 102) . Interestingly, the results of studies of Stra6-deficient mice suggest that there are other pathways facilitating retinol uptake into the RPE, but that the one involving Stra6 is the most important one (102) .
Over the last several years, a large number of published reports have suggested a link between RBP4 and obesity, diabetes and insulin signaling. The first of these studies looked at the impact of RBP4 levels in various mouse and human models (103) (104) (105) . RBP4 levels appear to be increased in human obesity and this increase impairs insulin signaling, possibly contributing to the development of type 2 diabetes, although the published studies are sometimes not in agreement (103) (104) (105) (106) (107) (108) (109) . There is also evidence now that STRA6 may be involved in mediating this effect of RBP4 on insulin signaling (110, 111) . We will further consider this topic below in "Retinoids and Adipose
Tissue."
Unlike retinol delivered bound to RBP4, which is thought to be taken up by cells through a process involving a cell surface receptor, RA uptake into tissues is not presently thought to involve a cell surface receptor. It is well established experimentally that RA can "flip-flop" across a phospholipid bilayer and it is generally assumed that it is taken up into cells from the circulation through this process (112, 113) . This same "flipflop" mechanism was earlier proposed to account for most unesterified fatty acid uptake by cells across the plasma membrane from the circulation (114) . However, it is now widely accepted that several plasma membrane proteins are responsible for most unesterified fatty acid uptake by tissues (115) . The possibility that RA also may be taken up into cells by one or more cell surface receptors has not been systematically explored and remains to be established.
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Retinoids and proretinoid carotenoids present in VLDL and LDL are presumably taken up along with the lipoprotein particles by their cell surface receptors, but this too has not been systematically investigated. Retinyl-and retinoly--glucuronides are fully water soluble and have been proposed to serves as a source of retinoids for use by tissues but it is unclear whether and how these may be taken up by cells (81, 82) .
Hepatic storage.
It is well established that hepatocytes are responsible for the uptake of chylomicron remnant retinoid into the liver (6, 7, 116-118). Hepatocytes not only take up postprandial retinoid into the liver but they also account for about 10-20% of all of the retinoid stored within the liver and are the sole cellular site of RBP4 synthesis in the liver (6, 7, 116, 119) . Moreover, hepatocytes possess enzymatic activities needed for the hydrolysis of retinyl esters and the synthesis and catabolism of retinoic acid. After postprandial retinoid is taken up by the hepatocyte, this retinoid is either secreted back into the circulation bound to RBP4 (see above for more details) or is transferred to the hepatic stellate cells (HSCs) for storage (6, 7, 119) . It has been estimated that for healthy well nourished individuals approximately 70% of the retinoid present in the body will be stored in the liver and approximately 70-90% of this is found in HSCs (6, 7, 116, 117, 119) . Within HSCs, retinoid is stored as retinyl esters in the large lipid droplets that are characteristic of these cells (see Figure 4) (6, 7, (117) (118) (119) . Nearly all of the retinoid present in HSCs is retinyl ester (primarily retinyl palmitate, with smaller amounts of retinyl stearate, retinyl oleate and retinyl linoleate) (116) (117) (118) (119) . Normally, unesterified retinol accounts for less than 1% of the total retinoid present within these cells.
When the body senses a need for retinoid, hepatic retinyl esters are hydrolyzed by REHs to free retinol, which through some poorly characterized process, is mobilized from the liver bound to its plasma transport protein, RBP4. Mice lacking RBP4 are unable to mobilize their retinoid stores, which are effectively trapped within the liver (71, 120, 121) . It remains to be established how a signal is conveyed from peripheral tissues to the liver regarding their need for retinoid, thus, stimulating retinoid mobilization from hepatic stores. Retinol-RBP4 is secreted from the liver into the circulation as a means of delivering retinol to peripheral tissues (56, 71) . The liver is the major site of synthesis of RBP4 in the body and within the liver the hepatocyte is the sole cellular site of RBP4 synthesis (56, 116, 119) . Other tissues including adipose tissue, kidney, lung, heart, skeletal muscle, spleen, eyes and testes also express RBP4
(56) and this may be important for recycling retinoid from peripheral tissues back to the liver (56, 117) .
One of the key unanswered questions regarding hepatic retinoid storage and metabolism is how retinoid(s) is (are) transported between hepatocytes and HSCs. It is well established that postprandial retinoid is take up by hepatocytes and equally well established that HSCs are the major cellular storage site for retinoid in the liver (6, 7, 116, 117, 119) . This immediately raises the question as to how dietary retinoid is transferred from hepatocytes to HSCs for storage. The early literature proposed that RBP4 was responsible for this intercellular movement and it was generally accepted that RBP4 was responsible for intercellular retinoid movement within the liver (117) .
However, studies of Rbp4-deficient mice indicate that this cannot be correct since these mutant mice possess normal HSC lipid droplet retinyl ester stores (71, 120, 121) .
This implies that other proteins/factors must be responsible for retinoid transport between these two hepatic cell types. Moreover, this transport needs to be bidirectional. Since the hepatocyte is the site of RBP4 synthesis in the liver, when dietary retinoid is insufficient, retinol newly released from HSC retinyl ester stores must be transported back to hepatocyte where it binds nascent apo-RBP4 for secretion into the circulation and delivery to peripheral tissues. A few early investigators proposed that CRBPI, which is found in high abundance in both hepatocytes and HSCs, mediates retinol transfer possibly by moving through/across cell-to-cell contacts which exist between hepatocytes and HSCs (6, 7, 88) . Other early authors had suggested that some unidentified protein was involved in facilitating this process (6, 7, 88) . In late 2012, Alapatt et al. reported the identification of a novel retinol transporter that is expressed primarily in mouse liver and intestine and which is able to bind RBP4
(naming this receptor RBP4 receptor-2 or RBPR2) (122) . It is possible that this protein has a role in intercellular retinol transfer within the liver. Interestingly, Alapatt et al.
report that RBPR2 shares considerable structural similarity with STRA6 (122) .
However, at present, these and other possibilities for explaining how retinol is transported between hepatocytes and HSCs remain to be established.
The lipid droplets present within HSCs are specialized for retinoid storage (6, 7, 119, 123) . The lipid composition of HSC lipid droplets isolated from control fed rats is unique and consists of approximately 40% retinyl ester, 32% triglyceride, 20%
cholesteryl ester and cholesterol, 6% phospholipid, and 2% unesterified fatty acids (123) . The relative lipid composition of these lipid droplets is dependent on dietary retinoid intake, with greater retinyl ester accumulation seen in rats fed an excess-retinol diet and diminished accumulation seen for rats fed a retinol-restricted diet (123) .
Changes in the triglyceride composition of the diet do not affect either the relative or absolute lipid composition of rat liver HSC lipid droplets (123) . A number of lipid droplet associated proteins, members of the perilipin family, are reported to be expressed by HSCs, including perilipin 2 and perilipin 3 (119) . Given the central role of HSC lipid droplets in retinoid storage and metabolism, both LRAT and REHs must be able to associate with these lipid droplets but this possibility remains to be elucidated. Interestingly, as illustrated in Figure 4 , the HSCs of Lrat-deficient mice lack lipid droplets. This observation was unexpected since the majority of lipid present in the HSC lipid droplets is not retinyl ester. This suggests that the synthesis of HSC lipid droplets is regulated in some manner that takes into account either LRAT presence and/or hepatic retinoid status.
One of the most intriguing questions that can be asked regarding hepatic retinoid storage concerns why more than 50% of all retinoid present in the body is stored in HSCs (for a healthy individual, 70% of what is present in the body is in the liver and 80-90% of this is in HSCs). Thus, although HSCs account for only approximately 8% of the total cells in the liver and only 1% of hepatic protein, they account for more than half of all retinoid present in the body (88, 119, 124, 125) . What evolutionary factors or processes are responsible for this? HSCs, upon activation, are known to play a major causal role in the development of hepatic disease (88, 119, 124, 125) . HSCs quickly lose their lipid droplets and retinoid stores during the process of activation (119, 124, 125) . Possibly HSC lipid droplet retinoid stores are needed to buffer against disease development, but this hypothesis remains to be established. In this regard, recently published data indicate that HSC retinoid stores do not protect against CCl 4 -induced fibrosis in mice (126) but they are required to ensure optimal liver regeneration in response to a 70% partial hepatectomy (127) .
Retinoids in adipose tissue.
The major tissue storage site for retinoid in the body is the liver. Other tissues including the eyes, lungs, adipose tissue, skin, testes and spleen have capacity to store retinoid, albeit at a lesser concentration than liver. Adipose tissue is able to accumulate significant retinyl ester stores (6, 7, 128) . The concentrations of retinol/retinyl esters in adipose tissue of rats and mice maintained on a control retinoid-sufficient diet are reported to be in the range of 6-7 µg total retinol (retinol + retinyl ester)/g tissue wet weight (128) . On a per gram of tissue basis this is much less than in the liver. For this same study (128) , hepatic total retinol levels were reported to average approximately 150 µg/g tissue wet weight. But considering that the liver contributes only 3-4% of the total mass of the body whereas adipose tissue can contribute a much greater percentage of total body mass, it was estimated that adipose tissue may account for as much as 15-20% of the total retinoid present in the body of a healthy well nourished rat maintained on a control chow diet (128) . Moreover, adipose tissue expresses RBP4, CRBPI and CRBPIII (63, 128, 129 RBP4 (128, 129) . Thus, the adipocyte must be considered to be an important cell type in the body for retinoid storage and mobilization.
As discussed above, mice totally lacking Lrat have no detectable retinyl esters in nearly all tissues, with the notable exception of adipose tissue (27, 28) . The adipose tissue of Lrat-deficient mice has, in fact, an elevation in retinyl esters compared to chow fed wild type mice. This is probably due to the inability of other tissues to store retinol. Moreover, this finding implies the presence of another enzyme capable of synthesizing retinyl esters within adipose tissue (28) . Although DGAT1 has been
shown to be capable of synthesizing retinyl esters in intestine, mice lacking both Lrat and Dgat1 expression display the same elevation of retinyl esters in adipose tissue, implying that there is another as yet unidentified enzyme active in adipocytes (28, 47) .
Like in the liver, retinyl esters stored in adipose tissue can be mobilized and secreted back into the circulation bound to RBP4 synthesized in adipocytes (55, (128) (129) (130) .
These retinyl esters are first hydrolyzed by hormone-sensitive lipase (HSL) which acts as a physiologically relevant REH in adipocytes (130, 131) . Mice lacking HSL expression are unable to hydrolyze adipocyte retinyl esters and this results in abnormal retinoid signaling leading to aberrant adipocyte differentiation (131) .
One of the most exciting recent findings from research focused on adipose retinoid physiology has been the observation by Kahn and colleagues that RBP4
synthesized by adipocytes and secreted into the circulation may have a role in modulating tissue responsiveness to insulin (103) (104) (105) 
